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TO THE EDITOR
CD146, also called melanoma cell
adhesion molecule, is a cell surface
adhesion molecule on endothelial cells
involved in homotypic and heterotypic
cell interactions (Bardin et al., 2001).
CD146 binding in endothelial cells
leads to a change in cellular permeabi-
lity, actin distribution, and redistribution
of NF-kB p50 to the nucleus. CD146
has been shown to be present on 1–3%
of circulating peripheral blood T cells in
healthy humans (Elshal et al., 2005).
CD146þ T cells have an effector
memory phenotype, demonstrate upregu-
lation of a cluster of genes involved with
adhesion, migration, homing, and inflam-
mation, and have enhanced binding to
endothelial monolayers in vitro (Elshal
et al., 2007). These features of the
CD146þ T cells in the peripheral circu-
lation have led to the speculation that
they represent a small pool of cells
primed for extravasation and/or homing
of activated T cells (Elshal et al., 2007;
Guezguez et al., 2007) in response
to inflammatory stimuli. Circulating
CD146þ T cells are elevated in
several inflammatory autoimmune
diseases, such as sarcoidosis,
inflammatory bowel disease, multiple
sclerosis, connective tissue disease,
and Behcet’s disease, and produce IL-
17 (Dagur et al., 2010, 2011; Larochelle
et al., 2012). Whether these cells have a
role at the site of active inflammation in
these diseases remains unknown.
Psoriasis, which is associated with
increased vascular inflammation
(Mehta et al., 2011) and access to both
peripheral blood and the disease target
tissue (e.g., skin), is ideal to study
CD146þ T cell phenotype and
function in an inflammatory condition.
Here we present findings from a well-
characterized patient population with
psoriasis using peripheral blood
samples and skin biopsies from
psoriatic lesions and uninvolved skin.
Forty-seven patients with psoriasis
and sixty-seven healthy controls were
included in this study. Diagnosis of
psoriasis was confirmed by a dermatol-
ogist, and severity was measured by the
percentage of body surface area invol-
ved and the validated Psoriasis Area and
Severity Index. Donor demographics
and characteristics are presented in
Supplementary Table S1 online. Skin
biopsies were isolated from a represen-
tative psoriatic target lesion (6 mm) and
are identified as lesional psoriatic skin.
Nonlesional skin biopsies were obtained
from a similar body area at least 10 cm
away from the nearest psoriasis skin
lesion. Frozen sections were obtained
from skin lesions for immunofluores-
cence studies, and all patients provided
written consent as part of an IRB-
approved study (NCT01778569).
Venous blood was collected in sodium
heparin vacutainers (Becton Dickinson
(BD), San Jose, CA). Cells were stained,
and flow cytometric analysis was
performed as previously described
(Guezguez et al., 2007). Skin biopsies
were digested in Collagenase IV (GIBCO
BRL no. 17104-019, Grand Island, NY) at
5mgml–1 in RPMI 1640 for 45 minutes,
stained, and then sorted in the same
manner as peripheral blood. The follow-
ing antibodies used for staining were
obtained from BD: CD3, CD4, CD8,
CD33, CD14, CD19, CD45, CD45-RO,
and CD146 (Clone P1H12). Anti-IL-17A
(clone ebio64DEC17) was purchased
from eBiosciences (Grand Island, NY).
Immunophenotyping results are expre-
ssed as means and standard errors of the
mean. RNA was isolated from sorted
CD146þ or CD146 T cell subpopu-
lations using RNAquos Micro kits
(Ambion, Grand Island, NY), and
quantitative real-time reverse-transcrip-
tase–PCR was performed using a
7900-sequence detector (PE-Applied
Biosystems, Norwalk, CT).
Data from a single specimen were
considered for one experiment (n). A P-
value o0.05 was considered statisti-
cally significant. Statistical analysis was
performed using STATA version 12.0
(Stata, College Station, TX).
To determine whether CD146þ
T cells are prevalent in patients with a
Th17 disorder, immunophenotyping was
performed on fresh peripheral blood
from patients with psoriasis. Psoriasis
patients showed a significant elevation
of circulating CD3þCD146þ T cells
compared with healthy adults (3.91±
0.37% vs. 2.96±0.19%, respectively,
P¼0.03; Figure 1a). Increased CD146
expression reached statistical signifi-
cance with the circulating CD4þ
T cells (5.50±0.413% in psoriasis vs.
3.55±0.213%, respectively, Po0.0001;
Figure 1b) but not the CD3þCD8þ
CD146þ T cells (2.75±0.373% in
psoriasis vs. 2.30±0.216%, respec-
tively; Figure 1c). CD146þ T cells were
abundant within lesional skin biopsies,Accepted article preview online 24 July 2014; published online 21 August 2014
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representing roughly 1/3 of the total
CD4þ T and CD8þ T-cell populations
(Figure 1b and c). Immunofluorescence
of frozen sections confirmed CD146þ
T cells in lesional skin biopsies
(Figure 1d). Lymphocytes, including
CD146þ T cells, were rare in the
biopsies of nonlesional, unaffected skin
from psoriasis patients.
To determine IL-17A production
from CD146 and CD146þ subsets
of psoriatic T cells, cell suspensions
from peripheral blood and lesional skin
were stimulated for 3 hours with
phorbol 12-myristate 13-acetate and
ionomycin, and stained for cell surface
markers and then for intracellular
IL-17A. CD146þ cells were the pri-
mary producers of IL-17A in lesional
skin for both CD4þ (67.8±9.5%,
Po0.005) and CD8þ (70.8±11.4%,
Po0.004) T cells (Figure 2a). In con-
trast, CD146þ cells accounted
for B20% of IL-17A producers in per-
ipheral blood from both healthy
adults and psoriatics. mRNA levels of
IL-17A, RORc2, and CD146 were
increased among unstimulated CD146þ
T cells compared with CD146 T cells,
in both blood and lesional skin, with a
greater elevation in the lesions
(Figure 2b).
Although previous studies have
demonstrated increased circulating Th17
cells in psoriasis (Kagami et al., 2010),
in this study we demonstrate that
CD146þ T cells produce the majority
of IL-17A at the active site of inflam-
mation in psoriasis. Our study confirms
previous reports of IL-17A production by
CD146þ T cells in both healthy
individuals and in patients with
various autoimmune disorders and
adds to those results by (1) extending
these findings to psoriasis and (2)
demonstrating that CD146þ T cells
are important mediators of inflam-
mation at the active site of disease.
These findings suggest that CD146þ T
cells in the circulation may represent a
pool of cells with the means to both
extravasate to the site of inflammation
(via CD146 expression) and mediate
inflammation at a specific site. Limita-
tions include analyzing patients with a
variety of topical and systemic therapy
and only studying patients with mild-to-
moderate psoriasis. Previous studies
examining this cell type in auto-
immune diseases have been limited by
not examining cells at the active site of
inflammation—a hindrance overcome
in the current work.
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Figure 1. CD146þ T cells are significantly elevated in patients with psoriasis in the circulation and at the site of inflammation. Comparative frequencies
(mean±SEM) of (a) CD3þCD146þ T cells, (b) CD3þCD4þCD146þ T cells, and (c) CD3þCD8þCD146þ T cells. (d) Immunofluorescence staining of a
frozen section from a lesion biopsy stained with CD146 and CD3. The lesion stained with both antibodies demonstrated the marked infiltration of T cells
expressing CD146, confirming the flow cytometric results.
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Figure 2. Production of IL-17A by CD146+ T cells in psoriasis. (a) Percentages of IL-17A-producing T cells, which are CD146 positive. The T cells and T cell
subsets secreting IL-17A were gated first and then the proportion of these cells expressing CD146 was determined. (b) Gene expression data illustrating IL-17A,
RoRC2, and CD146 mRNA in CD146þ and CD146 T cells from psoriatic lesions and peripheral blood.
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TO THE EDITOR
Given the recent discovery of RAC1-
activating mutations in melanoma, and
our finding that PIP3-dependent Rac-
exchanger 1 (PREX1) is overexpressed
and drives metastasis in this cancer, an
important question is to establish whe-
ther the functions of P-Rex1 are medi-
ated specifically by Rac alone (Lindsay
et al., 2011; Berger et al., 2012). Here
we describe a Rac1-independent in vivo
role for P-Rex1 through identification
and characterization of a mouse coat
color phenotype. P-Rex1 is a guanine-
nucleotide exchange factor (GEF) for
Rac, whose primary cell function is
induction of actin-mediated membrane
ruffling and lamellipodia formation at
the leading edge of cell migration
(Welch et al., 2002; Hill et al., 2005;
Barber et al., 2007).
To investigate this question we
decided to examine the role of Rac1
and P-Rex1 in melanoblast develop-
ment. Previously, we reported a ‘‘white
belly’’ phenotype of mice with Prex1
deletion (Lindsay et al., 2011). Impaired
melanoblast migration was mostly
responsible for this phenotype, with
melanoblasts lacking at the most distal
points of migration (belly and paws).
Constitutive deletion of Rac1 is
embryonically lethal, but a coat color
defect of mice with melanocyte-specific
RAC1 abrogation (Tyr::Cre Rac1fl/fl) has
also been described; these mice have a
larger belly spot on their ventral side,
suggesting that alternative Rho-GTPases
can be activated to enable melanoblast
migration to the perimeter of the
Tyr::Cre Racfl/fl white belly (Sugihara
et al., 1998; Li et al., 2011). A role for
Rac1 in proliferation was also observed,
as there was a marked reduction
of melanoblast numbers in this
phenotype. In line with these previous
studies, and because mice with melano-
cyte-specific RAC1 abrogation require
euthanization shortly after birth because
of neurological problems, we used the
same embryonic melanoblast reporter
models to assess the downstream
effects of P-Rex1 in vivo (Mackenzie
et al., 1997; Mort et al., 2010; Li
et al., 2011). Melanocyte-specific
reporter mouse strains employed were
Tyr::Cre Z/EG, which drives green
fluorescent protein expression in the
melanoblast lineage, and DCT::b-
galactosidase (otherwise referred to as
DCT-lacZ).
First, we hypothesized that, if the
effects of P-Rex1 were mediated exclu-
sively via Rac1, double mutant Tyr::Cre
Rac1fl/fl; P-Rex1 / mice would exhibit
the same coat color phenotype as
Tyr::Cre Racfl/fl mice alone. However,
Tyr::Cre Racfl/fl; P-Rex1 / mice dis-
play a dramatic alteration in coat color
phenotype from Tyr::Cre Racfl/fl mice
(n¼ 7; Figure 1a). The ventral and dorsal
coats of these mice are almost entirely
white, with hypo-pigmented limbs and
tail. Graying pigmented areas were only
observed in the head coat. We con-
cluded from this experiment that P-Rex1
and Rac1 together constitute fundamen-
tal signaling components of the mouse
coat color phenotype, with minimal
rescue of melanoblast development
conferred by other GEFs or Rho-
GTPases. It was also clear that P-Rex1
must be able to exert phenotypic effects
other than via Rac1.
To explore the Rac1-independent
effects of P-Rex1 further, we crossed
Tyr::Cre Racfl/fl; P-Rex1 / mice with
mice carrying the melanoblast reporter
DCT-lacZ transgene (methods detailed in
Lindsay et al., 2011). Relative to Tyr::Cre
Racfl/flmice or P-Rex1 / embryos
alone, Tyr::Cre Racfl/fl; P-Rex1 /Accepted article preview online 30 July 2014; published online 11 September 2014
Abbreviations: GEF, guanine-nucleotide exchange factor; OHT, 4-hydroxytamoxifen; PREX1, PIP3-
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